Alantra advises the shareholders of MEDWING on the sale of InSitu to Vivecti Group

Feb 2026

Sell-side advisory

Frankfurt – Alantra has acted as exclusive sell-side advisor to the shareholders of MEDWING, a German tech-enabled healthcare staffing and workforce-management platform, on the sale of InSitu Software GmbH to Vivecti Group, a healthcare performance platform owned by Nordic Capital.

InSitu Software GmbH delivers digital workforce management solutions to hospitals and care facilities across Germany, supporting the efficient deployment of internal and external staff through an integrated end-to-end platform. The business serves approximately 700 healthcare partners, with over 12,000 active users and more than four million completed bookings.

The transaction follows the sale of MEDWING’s International Recruiting business in December 2025 and represents the second completed transaction on which Alantra has advised MEDWING’s shareholders.

Christopher Jobst, Managing Director at Alantra, commented: “The sale of InSitu marks another important transaction for MEDWING’s shareholders and highlights the strategic relevance of digital workforce solutions in healthcare. As providers continue to face structural staffing shortages and increasing operational complexity, technology-enabled platforms such as InSitu are becoming increasingly important to the sector.”

This transaction further reinforces Alantra’s strong track record in Healthcare Services across Europe, including recent mandates such as advising Luxempart on its investment in Valeara, Affidea on the acquisition of Uroviva Group, and KIRKBI on its investment in AMBOSS.